Just one week ahead of its quarterly earnings, Illumina’s (ILMN) stock is making a big move. Shares jumped 7% on the stock market today, retaking its 50-day line in above-average volume. There’s anticipation that President Obama will announce during his State of the Union address a new government initiative to sequence 1 million genomes, which would be largely beneficial to Illumina since it dominates that market. Check out the above video for
Top-rated medical stocks such as Illumina (ILMN) are bullish on 2015. At the JPMorgan Healthcare Conference in San Francisco this week, several talked about earnings and sales prospects or announced new takeover deals. IBD’s Screen Of The Day is Big Cap Leaders, top-rated stocks generally priced above 15 with a market capitalization of at least $15 billion. Today’s screen includes five large drug and other medical stocks with proven track records.
Shares of gene-sequencing company Illumina (ILMN) rose more than 8% in afternoon trading on the stock market today, near an all-time high, as analysts hiked their estimates following the firm’s Q3 earnings report, released late Monday. Illumina’s Q3 earnings handily beat estimates and led to a 2014 guidance increase, which in turn led analysts to hike their 2015 numbers and in some cases their price targets. ISI Group analyst Ross Muken raised his